Trial intelligence / Profile preview

STOP-Trial: Stopping Antihypertensive Treatment in Primary Care

NCT02268071Completed

Sponsor
CHRU de Nancy - Hôpital Central
Start
Mar 2015
Primary completion
Oct 2020
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Rate of normotensive patients at 1 year. Started Mar 2015; status: completed.

Beyond the preview

Go deeper on NCT02268071.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02268071.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call